SCHEMBL4401736

SCHEMBL4401736

Cc1ccc2c3ccccc3n(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)c2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.57
ATM Q13315 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
HTT P42858 2/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
KIF11 P52732 1/20 0.40
GPR3 P46089 1/20 0.40
POLB P06746 1/20 0.38
METAP2 P50579 1/20 0.38
AKR1C4 P17516 1/20 0.37
AKR1C3 P42330 1/20 0.37
AKR1C2 P52895 1/20 0.37
AKR1C1 Q04828 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PTPN1 P18031 2/20 0.36
KMT2A Q03164 1/20 0.36
TP53 P04637 1/20 0.36
MAPK8 P45983 1/20 0.36
BCHE P06276 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13957098 1.00 KDM4E (0.57) KDM4EATML3MBTL1HTTLMNA
SCHEMBL680760 0.98 KDM4E (0.55) KDM4EATML3MBTL1HTTLMNA
SCHEMBL13957177 0.95 KDM4E (0.52) KDM4EATML3MBTL1HTTLMNA
SCHEMBL4406988 0.95 KDM4E (0.52) KDM4EATML3MBTL1HTTLMNA
SCHEMBL883474 0.94 KDM4E (0.67) KDM4EATML3MBTL1HTTLMNA
SCHEMBL16593078 0.93 KDM4E (0.60) KDM4EATML3MBTL1HTTLMNA
SCHEMBL23618576 0.92 KDM4E (0.48) KDM4EATML3MBTL1HTTLMNA
SCHEMBL15040914 0.92 KDM4E (0.53) KDM4EATML3MBTL1HTTLMNA
SCHEMBL24466220 0.92 ATM (0.48) KDM4EATML3MBTL1HTTLMNA
SCHEMBL1104947 0.91 KDM4E (0.62) KDM4EATML3MBTL1HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8324403-B2 Carbazole derivatives; excellent hole transporting property and satisfactory electron transporting, excellent durability against electric oxidation/reduction and a high triplet excitation level; high luminous efficiency and a long lifetime PIONEER CORPORATION (JP) 2012-12-04 US disclosed
US-8324403-B2 Carbazole derivatives; excellent hole transporting property and satisfactory electron transporting, excellent durability against electric oxidation/reduction and a high triplet excitation level; high luminous efficiency and a long lifetime PIONEER CORPORATION (JP) 2012-12-04 US disclosed
US-8168307-B2 Organic compound, charge transport material and organic electroluminescent device PIONEER CORPORATION (JP) 2012-05-01 US disclosed
US-8168307-B2 Organic compound, charge transport material and organic electroluminescent device PIONEER CORPORATION (JP) 2012-05-01 US disclosed
US-20090191426-A2 ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT PIONEER CORPORATION (JP) 2009-07-30 US disclosed
US-20090021146-A1 ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE PIONEER CORPORATION (JP) 2009-01-22 US disclosed
US-20090021146-A1 ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE PIONEER CORPORATION (JP) 2009-01-22 US disclosed
US-20080145699-A1 Organic Compound, Charge-Transporting Material, and Organic Electroluminescent Element PIONEER CORPORATION (JP) 2008-06-19 US disclosed
US-20080145699-A1 Organic Compound, Charge-Transporting Material, and Organic Electroluminescent Element PIONEER CORPORATION (JP) 2008-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090021146-A1 ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE SLC25A21, SLCO2A1, OCIAD2 KDM4E 2880/4885ATM 4296/4885L3MBTL1 690/4885
US-20090191426-A2 ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT SLC39A3, SLCO2A1, SLC39A11 KDM4E 3607/4885ATM 3886/4885L3MBTL1 1312/4885
US-20080145699-A1 Organic Compound, Charge-Transporting Material, and Organic Electroluminescent Element SLC39A3, SLCO2A1, SLC39A11 KDM4E 3607/4885ATM 3886/4885L3MBTL1 1312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.